A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated... by Sheehan, S, Harris, SA, Satti, I, Hokey, DA, Dheenadhayalan, V, Stockdale, L, Thomas, Z-R, Minhinnick, A, Wilkie, M, Vermaak, S, Meyer, J, O'Shea, MK, Pau, MG, Versteege, I, Douoguih, M, Hendriks, J, Sadoff, J, Landry, B, Moss, P, McShane, H

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants. by Fletcher, H, Snowden, M, Landry, B, Rida, W, Satti, I, Harris, S, Matsumiya, M, Tanner, R, O'Shea, M, Dheenadhayalan, V, Bogardus, L, Stockdale, L, Marsay, L, Chomka, A, Harrington-Kandt, R, Manjaly Thomas, Z, Naranbhai, V, Stylianou, E, Darboe, F, Penn-Nicholson, A, Nemes, E, Hatheril, M, Hussey, G, Mahomed, H, Tameris, M, McClain, J, Evans, T, Hanekom, W, Scriba, T, McShane, H

T-cell activation is an immune correlate of risk in BCG vaccinated infants by Fletcher, H, Snowden, M, Landry, B, Rida, W, Satti, I, Harris, S, Matsumiya, M, Tanner, R, O'Shea, M, Dheenadhayalan, V, Bogardus, L, Stockdale, L, Marsay, L, Chomka, A, Harrington-Kandt, R, Manjaly Thomas, Z, Naranbhai, V, Stylianou, E, Darboe, F, Penn-Nicholson, A, Nemes, E, Hatheril, M, Hussey, G, Mahomed, H, Tameris, M, McClain, J, Evans, T, Hanekom, W, Scriba, T, McShane, H